Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Djibouti
Djibouti: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 83.0% in 2025. ▲ Rising
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Djibouti, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Djibouti recorded 83.0% for diphtheria tetanus toxoid and pertussis third-dose (dtp3) in 2025.
The figure is up 7.8% on the previous year and down 1.2% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Djibouti peaked at 89.0% in 2008 and was at its lowest, 46.0%, in 2000.
Djibouti ranks 140th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Djibouti, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 46.0% | — |
| 2001 | 53.0% | +15.2% |
| 2002 | 62.0% | +17.0% |
| 2003 | 68.0% | +9.7% |
| 2004 | 64.0% | -5.9% |
| 2005 | 71.0% | +10.9% |
| 2006 | 72.0% | +1.4% |
| 2007 | 88.0% | +22.2% |
| 2008 | 89.0% | +1.1% |
| 2009 | 89.0% | +0.0% |
| 2010 | 88.0% | -1.1% |
| 2011 | 87.0% | -1.1% |
| 2012 | 81.0% | -6.9% |
| 2013 | 82.0% | +1.2% |
| 2014 | 78.0% | -4.9% |
| 2015 | 84.0% | +7.7% |
| 2016 | 68.0% | -19.0% |
| 2017 | 76.0% | +11.8% |
| 2018 | 84.0% | +10.5% |
| 2019 | 85.0% | +1.2% |
| 2020 | 70.0% | -17.6% |
| 2021 | 59.0% | -15.7% |
| 2022 | 59.0% | +0.0% |
| 2023 | 72.0% | +22.0% |
| 2024 | 77.0% | +6.9% |
| 2025 | 83.0% | +7.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 70.2% | 46.0% | 89.0% | 10 |
| 2010s | 81.3% | 68.0% | 88.0% | 10 |
| 2020s | 70.0% | 59.0% | 83.0% | 6 |
Countries ranked near Djibouti
- 140 Belize 83.0% compare
- 140 Timor-Leste 83.0% compare
- 140 Tanzania, United Republic of 83.0% compare
- 140 Cameroon 83.0% compare
- 140 Liberia 83.0% compare
More health data for Djibouti
- Un projection of annual infant deaths, annual growth rate -1.5 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2173 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,107 deaths per 1,000 people (2090)
- Number of infants who die before age 1 197 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 0 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 0 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 13 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Djibouti?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Djibouti was 83.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Djibouti?
- The highest recorded value was 89.0% in 2008.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Djibouti?
- The lowest recorded value was 46.0% in 2000.
- How does Djibouti rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Djibouti ranks 140th out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Djibouti?
- Over the last ten years it is down 1.2%. The long-run trend across the full record is rising.
- Where does this Djibouti data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).